Sinovac's vaccine efficacy less than 60pct in Brazil trial -report
Reuters
Posted at Jan 12 06:29 AM
The coronavirus vaccine developed by China's Sinovac Biotech showed a general efficacy of less than 60% in its late-stage trial in Brazil, a news website reported on Monday, citing two people who seen the results.
Read more »